CU20110123A7 - COCLEATE WITH ONLY MAMP - Google Patents

COCLEATE WITH ONLY MAMP

Info

Publication number
CU20110123A7
CU20110123A7 CU2011000123A CU20110123A CU20110123A7 CU 20110123 A7 CU20110123 A7 CU 20110123A7 CU 2011000123 A CU2011000123 A CU 2011000123A CU 20110123 A CU20110123 A CU 20110123A CU 20110123 A7 CU20110123 A7 CU 20110123A7
Authority
CU
Cuba
Prior art keywords
veterinary
adjuvants
human
cochlear structures
antibiotics
Prior art date
Application number
CU2011000123A
Other languages
Spanish (es)
Inventor
Martín Oliver Germán Pérez
Aznar Elizabeth González
Blanco Osmir Cabrera
Vignier Caridad Zayas
Rodríguez Sergio Sifontes
González Julio Antonio Balboa
Pérez Maribel Cuello
Alvarez Belkis Romeu
González Miriam De San Juan Bosco Lastre
Negrín Zenaida Rodríguez
Rodríguez Rosa Lydia Solís
Original Assignee
Ct De Bioactivos Químicos
Inst Finlay Ct De Investigación Producción De Vacunas Y Sueros
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct De Bioactivos Químicos, Inst Finlay Ct De Investigación Producción De Vacunas Y Sueros filed Critical Ct De Bioactivos Químicos
Priority to CU2011000123A priority Critical patent/CU20110123A7/en
Publication of CU20110123A7 publication Critical patent/CU20110123A7/en

Links

Abstract

La presente invención se relaciona con el campo de la inmunología, específicamente con la rama de los adyuvantes y las vacunas. El objetivo técnico que se persigue es obtener adyuvantes basados en estructuras cocleares no proteolipídicas ni lip´dicas que contengan patrones moleculares asociados a microbios (MAMP) y con la adición opcional de antibióticos/quimioterapéuticos con el fin de emplearlos como Adyuvantes Vacunales para el tratamiento y prevención de enfermedades veterinarias y humanas. Adicionalmente, estos serán empleados como inmunopotenciadores en formulaciones veterinarias y humanas. También es un objetivo técnico de esta patente emplear dichas novedosas estructuras cocleares con antígenos particulares adicionados o liberados in vivo por el efecto combinado de la inmunopotenciación y los antibióticos/quimioterapéuticos en enfermedades infecciosas para la obtención de vacunas terapéuticas veterinarias y humanas en la industria farmacéutica. La invención también se relaciona con el método de obtención de las estructuras cocleares estériles.The present invention relates to the field of immunology, specifically the branch of adjuvants and vaccines. The technical objective is to obtain adjuvants based on non-proteolipid or lipid cochlear structures that contain molecular patterns associated with microbes (MAMP) and with the optional addition of antibiotics / chemotherapeutics in order to use them as Vaccine Adjuvants for the treatment and prevention of veterinary and human diseases. Additionally, these will be used as immunopotentiators in veterinary and human formulations. It is also a technical objective of this patent to employ such novel cochlear structures with particular antigens added or released in vivo by the combined effect of immunopotentiation and antibiotics / chemotherapeutic agents in infectious diseases to obtain veterinary and human therapeutic vaccines in the pharmaceutical industry. The invention also relates to the method of obtaining sterile cochlear structures.

CU2011000123A 2011-05-31 2011-05-31 COCLEATE WITH ONLY MAMP CU20110123A7 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU2011000123A CU20110123A7 (en) 2011-05-31 2011-05-31 COCLEATE WITH ONLY MAMP

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU2011000123A CU20110123A7 (en) 2011-05-31 2011-05-31 COCLEATE WITH ONLY MAMP

Publications (1)

Publication Number Publication Date
CU20110123A7 true CU20110123A7 (en) 2013-06-28

Family

ID=53838253

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2011000123A CU20110123A7 (en) 2011-05-31 2011-05-31 COCLEATE WITH ONLY MAMP

Country Status (1)

Country Link
CU (1) CU20110123A7 (en)

Similar Documents

Publication Publication Date Title
CL2019003264A1 (en) Formulations for vaccines against neoplasia and methods for preparing the same. (divisional request 201703151)
GT201300243A (en) RAMIFIED 3-PHENYLPROPIONIC ACID DERIVATIVES AND ITS USE
CO6630162A2 (en) 1-amino -2-cyclopropylethylboronic acid derivatives
CY1117757T1 (en) MODIFIED RSV F PROTEINS AND METHODS OF USE
ECSP12011834A (en) Pharmaceutical composition, pharmaceutical dosage form, procedure for its preparation, methods for its treatment and its uses.
CU20190101A7 (en) SUBSTITUTED DIAZABICYCLIC IMIDAZOPYRIMIDINES
UY33370A (en) Pharmaceutical compositions comprising a DPP4 and pioglitazone inhibitor drug, preparation and use procedures
PE20151023A1 (en) TRIAZOLOPYRAZINES
CO6400193A2 (en) DICIANOPIRIDINS ALQUILAMINO-REPLACED AND ITS AMINO ACID ESTER PROPHARMS
GT201500025A (en) PHARMACEUTICAL COMBINATIONS THAT INCLUDE A B-RAF INHIBITOR, AN EGFR INHIBITOR AND OPTIONALLY A PI3K-ALFA INHIBITOR
UY33863A (en) METHODS AND MEDICINES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
BR112015007814A2 (en) diagnosis, prevention and treatment of joint disease
UY32457A (en) VACCINE OF THE INACTIVATED DENGUE VIRUS
BR112015006623A2 (en) laquinimod and pridopidine for the treatment of neurodegenerative diseases
CO6531414A2 (en) APTAMERS OF THE TISSULAR FACTOR INHIBITOR AND ITS USES AS A TREATMENT OF HEMORRHAGICAL DISORDERS
CL2018002692A1 (en) Bivalent vaccine against swine flu virus (divisional application 201701961)
BR112013000776A2 (en) Method and Formulation for Treatment of Sialic Acid Deficiency
BR112014007902A2 (en) pharmaceutical compositions comprising 40-o- (2-hydroxy) ethyl rapamycin
MX2015007753A (en) Vaccine composition for naive subjects.
BR112015018827A2 (en) oral pharmaceutical composition for oral mucositis and stomatitis treatment
CO2017007383A2 (en) Methods for using antisense oligonucleotides for smad7
UY35091A (en) MODIFIED RELEASE FORMULATIONS FOR OPROZOMIB
CY1118402T1 (en) USE OF SOURCE L3 AND / OR L5 AS A VACCINE OR AS A DIAGNOSIS FOR DISEASE DISEASE
CR20160529A (en) PHARMACEUTICAL COMPOSITIONS TO TREAT INFECTIOUS DISEASES
CR20110226A (en) COMPOSITION TO TREAT DISEASE